Category: Biolase Technology Inc.Syndicate content

Ex-CEO Pignatelli backs down, but not out, in spat with Biolase

August 1, 2014 by Arezu Sarvestani

Scorned Biolase ex-CEO Federico Pignatelli withdraws his lawsuit as the company urges shareholders to welcome new leadership and deny his bid for re-election to the board.

Pignatelli backs down in spat with Biolase

Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli agreed this week to withdraw his lawsuit against the dental devices maker, but he's still pursuing his personal investigation into the company's recent conduct.

DICOM Grid raises $6M in an inside funding round | Medtech funding for the week of July 21, 2014

July 25, 2014 by MassDevice

Here's a look at some of the top funding stories for medical device companies this week: DICOM Grid raises $6M for cloud-based medical imaging systems; Welch Allyn leads $7M round for Cardiac Insight; Biolase launches $12M private placement amid internal turmoil, shares soar; Trice Medical reels in $12M, ex-Embrella founder O'Donnell

DICOM Grid raises $6M for cloud-based medical imaging systems

July 18, 2014 by Arezu Sarvestani

DICOM Grids raises $6M for cloud-based imaging management

Biolase launches $12M private placement amid internal turmoil, shares soar

July 21, 2014 by Arezu Sarvestani

Wall Street rallies as dental laser maker Biolase raises $12 million through a private placement round, even as the company deals with an ongoing civil war involving ousted CEO Federico Pignatelli.

Biolase launches $12M private placement

California-based Biolase (NSDQ:BIOL) announced today that it secured $12 million in a private placement funding round, even as the company weathers the internal tumult following the ouster of former CEO Federico Pignatelli.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Ex-Biolase CEO isn't giving up without a fight

June 27, 2014 by Arezu Sarvestani

Ousted Biolase CEO Federico Pignatelli launches an investigation into the device maker, saying he suspects "wrongdoing, mismanagement and corporate governance failures."

Ex-Biolase CEO isn't giving up without a fight

Shares of Biolase (NSDQ:BIOL) got a modest boost today, even as a company insider announced a far-reaching investigation into the company's management under the suspicion of wrongdoing.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

CEO Pignatelli out after court-ordered shake-up at Biolase

June 17, 2014 by Brad Perriello

Biolase CEO Federico Pignatelli is out after a court-ordered shake-up at Biolase.

CEO Pignatelli out in court-ordered shakeup at Biolase

The boardroom and C-suite at Biolase (NSDQ:BIOL) got a shake-up this week following a Delaware Supreme Court decision in a lawsuit filed by Oracle Partners earlier this year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase vows to take another run at Fotona

June 13, 2014 by Brad Perriello

Biolase vows to amend its complaint after a federal judge shoots down its false advertising and defamation claims against rival dental laser maker Fotona.

Biolase vows to take another run at Fotona

A federal judge this month dismissed a Biolase (NSDQ:BIOL) lawsuit alleging false advertising and defamation by dental laser rival Fotona, but left the door open for an amended complaint.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific's peripherals buy bad news for Cardiovascular Systems? | Medtech Wall Street news for the week of May 19, 2014

May 22, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Is Boston Scientific's peripherals buy bad news for Cardiovascular Systems?; M&A: Medtech makers use acquisitions to fill niches; Report: Deals in the medical device sector rose 200% in Q1; CareFusion plans $1B debt offering; Activist investor Oracle revives proxy war at Biolase.

Is Boston Scientific's peripherals buy bad news for Cardiovascular Systems?

May 15, 2014 by Arezu Sarvestani

Is Boston Scientific's peripherals buy bad news for Cardiovascular Systems?
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp